12/19/2014 - 7:14am
Rinovum Women’s Health, a privately held, U.S.-based women’s health company, announced Friday that it has secured $3 million in a series C financing from its existing investor base.
12/18/2014 - 10:44am

Dr. Reddy’s Laboratories announced Tuesday that it has launched Valganciclovir Tablets USP 450 mg, a therapeutic equivalent generic version of the antiviral Valcyte (Valganciclovir) tablets, in the U.S. market.

12/17/2014 - 3:49pm

The Food and Drug Administration on Wednesday approved Xtoro (finafloxacin otic suspension), a new drug that's used to treat acute otitis externa, commonly known as swimmer's ear. 

12/17/2014 - 2:05pm

PL Developments on Wednesday announced that it has added menopause relief supplement, EstroG-100, to its private-label portfolio.

12/17/2014 - 12:41pm

Skin care company Adovia has debuted its new Natural Sulfur Soap enriched with minerals and sulfur from the Dead Sea.

12/17/2014 - 11:36am

Ipsen Biopharmaceuticals on Tuesday announced that Somatuline Depot (lanreotide) Injection 120 mg (referred to as Somatuline) was approved by the U.S. Food and Drug Administration for the treatment of gastroenteropancreatic neuroendocrine tumors.

12/17/2014 - 11:24am

To date, the Food and Drug Administration's Center for Drug Evaluation and Research has approved 35 novel new drugs in 2014, compared to 27 in 2013. 

12/16/2014 - 11:26am

 Greenstone announced the launch of celecoxib — the authorized generic version of Pfizer's Celebrex — to its line of generic pharmaceuticals. 

12/16/2014 - 10:27am

Novartis on Tuesday received approval from the Food and Drug Administration for Signifor long-acting release (pasireotide) for injectable suspension, for intramuscular use.